CEBPA and cervical carcinoma: According to the IPA analysis of differentially expressed genes, qPCR was used to verify KCP could also act positively on the downstream gene of SERPINB3 and negatively on the downstream gene of CEBPA to affect the resistance of cervical carcinoma to paclitaxel.